Famotidine
- Product NDC
- 68071-3201
- 11-digit product format
- 680713201
- Labeler code
- 68071
- Product ID
- 68071-3201_1da0eabf-a0b1-c4aa-e063-6394a90ab10e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Famotidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA078916
- Marketing category
- ANDA
- Marketing start
- 2016-01-29
- Substance
- FAMOTIDINE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Famotidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FAMOTIDINE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5QZO15J2Z8 |
| Rxcui | 310273 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 68071-3201-2 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-3 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-6 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-8 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-9 | 2024-07-19 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-2 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-3 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-6 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-8 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-9 | 2023-01-30 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-2 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-3 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-6 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-8 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-9 | 2021-02-11 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-6 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-8 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
| 68071-3201-9 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4371-a910-e053-dadaa90a0b85 | Famotidine Tablets, USP Rx only |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-3201-2 | Famotidine | 20 in 1 BOTTLE | TABLET | 20 | | 5 |
| 68071-3201-3 | Famotidine | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
| 68071-3201-6 | Famotidine | 60 in 1 BOTTLE | TABLET | 60 | | 5 |
| 68071-3201-8 | Famotidine | 180 in 1 BOTTLE | TABLET | 180 | | 5 |
| 68071-3201-9 | Famotidine | 90 in 1 BOTTLE | TABLET | 90 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-3201 | FAMOTIDINE TABLET [NUCARE PHARMACEUTICALS, INC.] | 5 | Current NDC, Legacy NDC, 5 package rows | 20240720_4b820924-24ad-4a2f-e054-00144ff88e88.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-3201-2 | 68071320102 | 20 TABLET in 1 BOTTLE (68071-3201-2) | 20 tablet | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-3201-3 | 68071320103 | 30 TABLET in 1 BOTTLE (68071-3201-3) | 30 tablet | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-3201-6 | 68071320106 | 60 TABLET in 1 BOTTLE (68071-3201-6) | 60 tablet | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-3201-8 | 68071320108 | 180 TABLET in 1 BOTTLE (68071-3201-8) | 180 tablet | 2017-03-24 | 0000-00-00 | No | No | Current |
| 68071-3201-9 | 68071320109 | 90 TABLET in 1 BOTTLE (68071-3201-9) | 90 tablet | 2017-03-24 | 0000-00-00 | No | No | Current |